サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1347567

分子診断市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
分子診断市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の分子診断市場規模は2022年に185億米ドルに達しました。今後、IMARC Groupは、2023～2028年の成長率（CAGR）は6.5%で、2028年には274億米ドルに達すると予測しています。

分子診断は、デオキシリボ核酸（DNA）、リボ核酸（RNA）、または潜在的な疾患のバイオマーカーを分析するために、個人の細胞タンパク質を配列する一連の臨床検査を指します。感染症や疾患の診断やモニタリング、リスクの検出、治療反応の評価などに役立ちます。近年、分子診断は、腫瘍学、薬理ゲノミクス、微生物学、感染症、遺伝病スクリーニング、血液スクリーニングの分野で急速に普及しています。最近の進歩に伴い、分子診断は患者に合わせた介入や治療に不可欠なものとなっており、その需要は世界中で拡大しています。

分子診断市場の動向：

分子診断は、疾病の早期発見、凝固、ヒト白血球抗原タイピングのために病院、研究所、研究機関で広く使用されています。その結果、がん、心血管疾患（CVDs）、神経疾患、感染症などの慢性疾患の有病率が上昇していることが、市場成長を促進する主な要因となっています。これに加えて、多くの病気を発症しやすい高齢者人口の増加や、ポイント・オブ・ケア（POC）検査装置の普及が、製品需要を刺激しています。さらに、最近のコロナウイルス感染症（COVID-19）の発生は、COVID-19検査のためのポリメラーゼ連鎖反応（PCR）などの分子診断の採用を加速させています。これとともに、ウイルスの蔓延を抑制するための診断用製品の迅速な承認など、各国の行政機関や規制当局が実施するいくつかの好意的な取り組みも、市場の成長を後押ししています。さらに、主要企業は、製品ポートフォリオを拡大し、競争優位性を獲得するために、精度、柔軟性、費用対効果、迅速な結果を提供する革新的な診断装置を発売するために多額の投資を行っています。個別化治療に対する需要の高まり、予防医学のトレンドの台頭、ヘルスケアインフラの改善、技術の進歩など、その他の動向も市場の見通しを明るいものにしています。

本レポートで扱う主な質問

  • 世界の分子診断市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の分子診断市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の分子診断市場の構造と主要プレーヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 分子診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬・キット
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測
  • ソフトウェアとサービス
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
    • 市場動向
    • 市場予測
  • ハイブリダイゼーション
    • 市場動向
    • 市場予測
  • DNAシーケンス
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測
  • 等温核酸増幅技術（INAAT）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 感染症診断
    • 市場動向
    • 市場予測
  • がん領域
    • 市場動向
    • 市場予測
  • 遺伝子検査
    • 市場動向
    • 市場予測
  • 血液スクリーニング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Biomerieux SA
    • Danaher Corporation
    • Diasorin Molecular LLC（DiaSorin S.p.A.）
    • F. Hoffmann-La Roche AG（Roche Holding AG）
    • Hologic Inc.
    • Illumina Inc.
    • Myriad Genetics Inc.
    • Qiagen
    • Quidel Corporation
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2022
  • Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
  • Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2023-2028
  • Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Molecular Diagnostics Market: Key Players
目次
Product Code: SR112023A5726

Market Overview:

The global molecular diagnostics market size reached US$ 18.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.

Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.

Molecular Diagnostics Market Trends:

Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end users.

Breakup by Product:

Reagents and Kits

Instruments

Software and Services

Breakup by Technology:

Polymerase Chain Reactions (PCR)

Hybridization

DNA Sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases Diagnostics

Oncology

Genetic Testing

Blood Screening

Others

Breakup by End Users:

Hospitals

Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genetic Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Screening
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerieux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Hologic Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Qiagen
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quidel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis